1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Büttner T, Rizzo M, Bernal Vaca L, Molina-Cerrillo J, Alonso-Gordoa T, Juárez A, Buchler T, Seront E, Kucharz J, Gandur Quiroga MN, Bourlon MT, Bögemann M, Kopecky J, Rescigno P, Fiala O, Rodriguez-Vida A, Myint ZW, Ürün Y, Scagliarini S, Poprach A, Matthews D, Li H, Rizzo A, Mosca A, Lenci E, Melichar B, Wenzel M, Mandell P, Massari F, Antonarakis ES, Santoni M.

    Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

    PROSTATE CANCER AND PROSTATIC DISEASES . 29(3): 588-594. Nº de citas: 8

    [doi:10.1038/s41391-025-01067-3]

  • Guerrero Serrano P, Sotoca P, García A, Calvo JC, González-Merino C, de Quevedo CG, Subiela JD, Bueno C, Albarrán V, Molina A, Pérez-Valderrama B, Gajate P.

    DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

    ONCOLOGIST . 31(9): .

    [doi:10.1093/oncolo/oyag284]

  • Slusarczyk A, Moschini M, Krajewski W, Scilipoti P, Caño Velasco J, Mertens LS, Mori K, Subiela JD, Garbas K, Del Olmo Duran P, Claps F, Contieri R, Domanski P, Tully K, Grobet-Jeandin E, Puentedura AL, Lijnen RAG, Fertitta G, Longoni M, Del Giudice F, Gallioli A, Laukhtina E, Marcq G, Mari A, Amodeo A, Afferi L, Albisinni S, Boorjian SA, Soria F, Briganti A, Shariat SF, Gontero P, Radziszewski P, Pradere B.

    Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer.

    ANNALS OF SURGICAL ONCOLOGY . 33(8): 7732-7745.

    [doi:10.1245/s10434-026-19476-6]

  • Toquero P, Castillo L, José LS, Alfranca A, Celada G, Velasco C, Figols L, Prada C, Pacheco M, Gajate P, Pernaut C, Martínez I, Colomer R, Romero-Laorden N.

    Immune Phenotype in Urothelial Carcinoma: From Tumor Biology to Therapeutic Stratification.

    Cancers . 18(15): .

    [doi:10.3390/cancers18152392]

  • Grande E, Sibai M, Grases D, Andrada E, Reig O, Escobosa M, Azueta A, Castellano D, Puente J, Martínez de Villarreal J, Font A, Alonso-Gordoa T, Benítez R, Moreno-Oya A, Álvarez-Maestro M, Burgos J, Climent MA, Domínguez M, Galván P, Galante I, García JF, Perez E, García Del Muro X, Guerrero-Ramos F, Marqués M, Maroto P, Paramio JM, Pinto A, Prat A, Malats N, Durán I, Porta-Pardo E, Real FX.

    Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

    Cell Reports Medicine . 7(7): 102878-102878.

    [doi:10.1016/j.xcrm.2026.102878]

  • Polanco-Pujol L, Caño-Velasco J, Tapia-Tapia M, Barbas-Bernardos G, Labairu-Huertas L, Sánchez-Zalabardo D, Villacampa-Aubá F, González-Padilla D, Ancizu-Marckert FJ, Diez-Caballero-Alonso F, Robles-García JE, Subiela JD, Miñana-López B.

    Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.

    Diagnostics . 16(14): .

    [doi:10.3390/diagnostics16142187]

  • Roviello G, Ciccimarra F, Urabe F, Melichar B, Studentova H, Niedersuess-Beke D, Mota A, Büttner T, Gómez de Liaño A, Yano A, Myint ZW, Kopp RM, Zgura A, Pinto A, Angel M, Tural D, Kanesvaran R, Ürün Y, Molina-Cerrillo J, Marques Monteiro FS, Massari F, Fiala O, Santoni M, Antonuzzo L, Rizzo A.

    Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

    ESMO Open . 11(7): 108302-108302.

    [doi:10.1016/j.esmoop.2026.108302]

  • Wafa H, van Creij NCH, Guenther M, Noeparast M, Subiela JD, Terbuch A, Niedersuess-Beke D, Culig Z, Ormanns S, Pichler R.

    Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugates.

    CANCER TREATMENT REVIEWS . 148: 103173-103173.

    [doi:10.1016/j.ctrv.2026.103173]

  • Jatana S, Verhoeff K, Wang Y, Wang Z, Zhou J, Wu X, Chen Y, Sledzinski M, Hellmann A, Raffaelli M, Pennestrì F, Sywak MS, Papachristos A, Palazzo FF, Sung TY, Kim BC, Lee YM, Eatock F, Anderson H, Iacobone M, Gray DK, Chaulk RC, Kosmoliaptsis V, Colucci N, Spiers HVM, Daukša A, Makay Ö, Türk Y, Basut Atalay H, Nieveen van Dijkum EJM, Engelsman AF, Holscher I, Materazzi G, Rossi L, Becucci C, Shore SL, Fung C, Waghorn A, Mihai R, Balasubramanian S, Pannu A, Tatarano S, Velázquez-Fernández D, Miller JA, Serrao-Brown H, Chen Y, Demarchi MS, Djafarrian R, Doran H, Stechman MJ, Perry H, Hubbard JGH, Lamas C, Mercer P, MacPherson J, Lumbiganon S, Calatayud M, Hanzu FA, Vidal O, Araujo-Castro M, Minguez Ojeda C, Papavramidis T, Rodríguez de Vera Gómez P, Aldrees A, Altwjry T, Valdés N, Álvarez-Escola C, García Sanz I, Blanco Carrera C, Manjón-Miguélez L, De Miguel Novoa MP, Recasens M, García-Centeno R, Robles Lázaro C, Van Den Heede K, Van Slycke S, Michalopoulou T, Aspinall S, Melvin R, Wen Liang Lau J, Cheah WK, Tang MH, Oh HB, Ayuk J, Parente A, Sutcliffe RP.

    Evaluation of differences in presentation and postoperative outcomes after adrenalectomy for pheochromocytoma according to age.

    Endocrine Connections . 15(7): .

    [doi:10.1530/EC-25-0604]

  • Fernández-Mardomingo Díaz A, Artiles Medina A, López Curtis D, Mínguez Ojeda C, Subiela JD, González Tello F, Sanz Mayayo E, De la Parra Sánchez I, Gómez Dos Santos V, Burgos Revilla FJ.

    Bosniak IIF renal cysts: natural history and the impact of lesion size on progression.

    INTERNATIONAL UROLOGY AND NEPHROLOGY . 58(7): 2513-2519. Nº de citas: 1

    [doi:10.1007/s11255-025-04984-3]

  • Rioja P, Passarella C, Angel M, Valderrama W, Ainaud FB, Anguera G, Gómez V, Ruiz-Granados Á, Plata D, Zapata MI, Orta-Ruiz A, Quiroga MNG, Bourlon MT, Grande E, Ray Manneh Kopp, Molina-Cerrillo J, Maroto P, Sade JP, Castellano D.

    Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(7): 225-233.

    [doi:10.1016/j.urolonc.2026.04.008]

  • Artiles Medina A, Subiela JD, Muriel García A, Domínguez Gutiérrez A, Gómez Dos Santos V, Álvarez Díaz N, Tagalos Muñoz A, López Curtis D, Mínguez Ojeda C, de la Parra Sánchez I, Crespo L, Coloma Del Peso A, Burgos Revilla FJ.

    A systematic review and meta-analysis of clinicopathologic factors associated with adverse oncologic outcomes in bladder cancer patients undergoing radical cystectomy: Evidence from multivariable survival prediction models.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(7): 258-271.

    [doi:10.1016/j.urolonc.2026.03.003]

  • Hevia M, Dominguez A, Fraile A, Saenz-Medina J, Rodríguez-Patrón R, Martin E, Cordoba L, Burgos-Revilla FJ.

    Perineal approach with penile invagination for one-stage oral mucosa graft urethroplasty in adults with hypospadias-associated strictures.

    Translational Andrology and Urology . 15(6): 212-212.

    [doi:10.21037/tau-2026-1-0004]

  • Scilipoti P, de Angelis M, Thibault C, Slusarczyk A, Del Giudice F, Contieri R, Hurle R, Subiela JD, Simone G, Proietti F, Mori K, Shariat S, D'Andrea D, Zamboni S, Suardi N, Tanaka H, Matsumoto S, Fujii Y, Bertolo R, Antonelli A, Diamant E, Vordos D, Gabriel PE, Harber T, Colombel M, Hanquiez P, Chatain V, Duquesne I, Borz MB, Verhoest G, Mauger De Varennes A, Surlemont L, Ghenassia M, Masson-Lecomte A, Peyrottes A, Lebacle C, Beniac P, Léon P, Larré S, Taha F, Marcq G, Szostek A, Pradere B, Calleris G, Audenet F, Xylinas E, Allory Y, Bajeot AS, Prost D, Grobet-Jeandin E, Montorsi F, Necchi A, Briganti A, Moschini M, Roumiguié M, Rouprêt M, Seisen T.

    Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

    Journal of the National Comprehensive Cancer Network . 24(7): .

    [doi:10.6004/jnccn.2026.7014]

  • Santarelli V, Asero V, Corvino R, De Berardinis E, Sciarra A, Basile G, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Grobet-Jeandin E, Reynard M, Mari A, Mertens LS, Soria F, Teoh J, Claps F, Amodeo A, Slusarczyk A, Contieri R, Perdonà S, Subiela JD, Tully KH, Pichler R, Antonelli A, Bertolo R, Ditonno F, Hurle R, Crocetto F, Mayr R, Porreca A, Marino F, Simone G, Tuderti G, Rocco BMC, Sighinolfi C, Vittori L, Moschini M, Zaurito P, De Angelis M, Scillipoti P, Afferi L, De Groote R, De Naeyer G, Mottrie A, Pavan N, Chung BI, Marcq G, Pradere B, Del Giudice F.

    Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

    WORLD JOURNAL OF UROLOGY . 44(1): .

    [doi:10.1007/s00345-026-06520-z]

  • Mascaró-Baselga P, Rodellar Sanz JM, Nunes da Silva T, Hernando J, García-Álvarez A, González Merino C, Molina-Cerrillo J, Fernandez-Pombo A, Iglesias-Alvarez G, Ceballos Lenza I, Plana Serrahima M, Bella Cueto MR, Isidro ML, Martinez Trufero J, Marquina G, Martinez N, Crespo G, Jimeno R, Lorenzo I, Ayala de Miguel P, Alcazar V, Martínez-Badal S, Capdevila J, Alonso-Gordoa T.

    Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

    ONCOLOGIST . 31(7): .

    [doi:10.1093/oncolo/oyag158]

  • Gallioli A, Bello FD, Laukhtina E, D'Andrea D, Beltrami P, Celso FG, Krajewski W, Afferi L, Soria F, Marcq G, Giudice FD, Lorenzis E, Moschini M, Mari A, Subiela JD, Baboudjian M, Avesani G, Territo A, Basile G, Diéguez L, Izquierdo P, Palou J, Pradere B, Breda A.

    The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working Group.

    European Urology Open Science . 88: 31-38.

    [doi:10.1016/j.euros.2026.03.008]

  • Molina-Cerrillo J, Sierra-Ramirez A, López-Aceituno JL, Méndez-Pertuz M, Alonso-Gordoa T, Linnebacher M, Santoni M, Fernandez-Marcos PJ, Grande E.

    A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors.

    DRUGS IN R&D . 26(2): 155-167.

    [doi:10.1007/s40268-026-00544-x]